Recombinant Mouse Trefoil Factor 1/TFF1 Protein (His Tag) | PKSM041269

Recombinant Mouse Trefoil Factor 1/TFF1 Protein (His Tag) | PKSM041269 | Gentaur US, UK & Europe Disrtribition

Synonyms: Trefoil factor 1; Protein pS2; Tff1; Bcei; Ps2

Active Protein: N/A

Activity: Recombinant Mouse Trefoil Factor 1 is produced by our Mammalian expression system and the target gene encoding Gln22-Phe87 is expressed with a 6His tag at the C-terminus.

Protein Construction: Recombinant Mouse Trefoil Factor 1 is produced by our Mammalian expression system and the target gene encoding Gln22-Phe87 is expressed with a 6His tag at the C-terminus.

Fusion Tag: C-His

Species: Mouse

Expressed Host: Human Cells

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per μg as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 8.3 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Reconstitution: Please refer to the printed manual for detailed information.

Background: Trefoil Factor 1 (TFF1) belongs to the three structurally related secreted proteins that contain trefoil domains.TFF1 is an approximately peptide that has an important effect in epithelial regeneration and wound healing.It originates from musculus and highly expressed by goblet cells of the gastric and intestinal mucosa and by conjunctival goblet cells. TFF1 is a copper-binding protein that can form disulfide-linked homodimers, associate into disulfide-linked complexes with Gastrokine 2, and form non-covalent complexes with the mucin MUC5AC. TFF1 is down-regulated during the progression from gastritis to gastric dysplasia to gastric cancer, although it is up-regulated in breast and prostate cancers. TFF1 inhibits the formation of calcium oxalate crystals, and its excretion in the urine is reduced in patients with kidney stones.

Research Area: N/A